Type 2 Diabetes News and Research

Latest Type 2 Diabetes News and Research

Understanding the social determinants of cardiovascular health in Asian Americans

Numerous social and structural factors, including immigration status, socioeconomic position and access to health care, contribute to differences in cardiovascular health and heart disease risk for Asian Americans, and these factors affect Asian ethnic subgroups in different ways, according to a new scientific statement published today in the American Heart Association's journal, Circulation.

16 Sep 2024

Hormone therapy found to improve insulin sensitivity in menopausal women

Menopausal women are at greater risk of insulin resistance as a result of declining estrogen levels. Previous studies evaluating the potential benefits of hormone therapy on insulin resistance have produced mixed results.

16 Sep 2024

Reducing ultra-processed foods can lower type 2 diabetes risk

People who eat more ultra-processed foods (UPF) are at increased risk of developing type 2 diabetes, but this risk can be lowered by consuming less processed foods instead, finds a new study led by researchers at UCL.

16 Sep 2024

Do organic foods really offer better health benefits?

Researchers compare the health impacts of consuming organic foods to conventional alternatives.

16 Sep 2024

Higher soft drink consumption linked to increased risk of liver disease

Study found that higher soft drink consumption is associated with an increased risk of nonalcoholic fatty liver disease, especially in males, within a cohort of Mexican adults.

16 Sep 2024

Real-world data reveals factors associated with long-term weight loss in obesity

A Cleveland Clinic study identified key factors that can impact the long-term weight loss of patients with obesity who were prescribed injectable semaglutide or liraglutide for the treatment of type 2 diabetes or obesity. The study was published in JAMA Network Open.

14 Sep 2024

Semaglutide and tirzepatide significantly improve weight loss and glycemic control in type 1 diabetes

Semaglutide and tirzepatide treatment lead to significant weight loss and improve blood sugar control in individuals with type 1 diabetes (T1D) who are living with overweight or obesity, new research being presented at the annual meeting of the European Association for the Study of Diabetes (EASD) in Madrid, Spain (9-13 September) has found.

13 Sep 2024

Obesity medication liraglutide is safe and effective in children aged 6 to <12 years

Liraglutide treatment significantly lowers BMI in obese children aged 6 to <12, but gastrointestinal side effects prompt the need for additional studies.

13 Sep 2024

Research highlights cardiovascular benefits of semaglutide for overweight adults with impaired kidney function

The anti-obesity medication semaglutide may help to prevent heart attacks, strokes, and other major adverse cardiovascular events (MACE) as well as death in adults with overweight or obesity who don't have diabetes, whether or not they also have impaired kidney function, according to new research to be presented at this year's Annual Meeting of The European Association for the Study of Diabetes (EASD), Madrid (9-13 Sept).

13 Sep 2024

Real-world evidence highlights safety profile of tirzepatide in managing type 2 diabetes

As more people with type 2 diabetes (T2D) are taking medications to help manage blood sugar levels and weight loss, concerns about whether these drugs are safe have emerged.

12 Sep 2024

Early lifestyle changes lead to lasting impacts on metabolism

A new study from the University of Eastern Finland (UEF) uncovers how early lifestyle changes can have long-lasting impacts.

12 Sep 2024

Women experience greater weight loss with tirzepatide compared to men

All doses of tirzepatide, a medication approved in the EU to treat type 2 diabetes and obesity, consistently reduced body weight in women and men, but women experienced greater weight loss, according to new post hoc research to be presented at this year's Annual Meeting of The European Association for the Study of Diabetes (EASD), Madrid (9-13 Sept).

11 Sep 2024

Klick Labs unveils voice technology for detecting hypertension with high accuracy

Researchers at Klick Labs unveiled a cutting-edge, non-invasive technique that can predict chronic high blood pressure (hypertension) with a high degree of accuracy using just a person's voice.

11 Sep 2024

New molecular map offers insights into human physiology and disease

Scientists at Weill Cornell Medicine in Qatar (WCM-Q) have created an intricate molecular map of the human body and its complex physiological processes based on the analysis of thousands of molecules measured in blood, urine and saliva samples from 391 volunteers.

11 Sep 2024

Distinct gut bacteria identified in octogenarians linked to aging and health

Research reveals unique gut bacteria in Singaporean seniors, highlighting the microbiome's role in promoting healthier aging and reducing chronic disorders.

11 Sep 2024

Obesity increases risk of contracting COVID-19 after exposure to SARS-CoV-2

Researchers reveal that obesity also increases the risk of contracting COVID-19 following exposure to SARS-CoV-2.

11 Sep 2024

A promising new therapeutic target for MASLD identified

Using a novel stem cell platform, a team of the Medical University of South Carolina researchers has identified a pathway that could be targeted by drugs to reduce fat accumulation in patients with a common form of fatty liver disease known as metabolic dysfunction-associated steatotic liver disease, or MASLD.

11 Sep 2024

Promising new approach to combat HIV

Researchers at Université de Montréal's affiliated hospital research center, the CRCHUM, say the discovery could help lessen and even eliminate viral loads in people undergoing antiretroviral therapy.

11 Sep 2024

Eight-hour eating window improves blood glucose control in prediabetic adults

Restricting the eating window to 8 hours a day significantly improves blood glucose control in adults at risk of type 2 diabetes irrespective of whether it is earlier or later in the day, according to a randomised crossover trial to be presented at this year's Annual Meeting of The European Association for the Study of Diabetes (EASD), Madrid (9-13 Sept).

10 Sep 2024

Diligence associated with better cardiovascular outcomes in type 2 diabetes patients

People with type 2 diabetes, who display lower levels of diligence, may have a significantly higher risk of developing cardiovascular disease with which diabetes is strongly associated, finds research published in the open access journal BMJ Open Diabetes Research & Care.

10 Sep 2024

Type 2 Diabetes News and Research

Latest Type 2 Diabetes News and Research

Understanding the social determinants of cardiovascular health in Asian Americans

Hormone therapy found to improve insulin sensitivity in menopausal women

Reducing ultra-processed foods can lower type 2 diabetes risk

Do organic foods really offer better health benefits?

Higher soft drink consumption linked to increased risk of liver disease

Real-world data reveals factors associated with long-term weight loss in obesity

Semaglutide and tirzepatide significantly improve weight loss and glycemic control in type 1 diabetes

Obesity medication liraglutide is safe and effective in children aged 6 to <12 years

Research highlights cardiovascular benefits of semaglutide for overweight adults with impaired kidney function

Real-world evidence highlights safety profile of tirzepatide in managing type 2 diabetes

Early lifestyle changes lead to lasting impacts on metabolism

Women experience greater weight loss with tirzepatide compared to men

Klick Labs unveils voice technology for detecting hypertension with high accuracy

New molecular map offers insights into human physiology and disease

Distinct gut bacteria identified in octogenarians linked to aging and health

Obesity increases risk of contracting COVID-19 after exposure to SARS-CoV-2

A promising new therapeutic target for MASLD identified

Promising new approach to combat HIV

Eight-hour eating window improves blood glucose control in prediabetic adults

Diligence associated with better cardiovascular outcomes in type 2 diabetes patients

Exploring the G:Box and for high-quality imaging

Shaping the Future of Neuroscience: A Conversation with Atlas Antibodies on the MolBoolean™ and the Impact of SfN 2024

How the Arts Reshape Brain Function: Susan Magsamen on the Future of Neuroaesthetics

Type 2 Diabetes News and Research

Latest Type 2 Diabetes News and Research

Exploring the G:Box and for high-quality imaging

Shaping the Future of Neuroscience: A Conversation with Atlas Antibodies on the MolBoolean™ and the Impact of SfN 2024

How the Arts Reshape Brain Function: Susan Magsamen on the Future of Neuroaesthetics

Newsletters you may be interested in